Nanogel-Based Antifungal Drug Delivery Systems: Advances in Design, Characterization, Therapeutic Applications, and Future Directions

Fungal infections present an urgent global health challenge, affecting more than one billion people worldwide and resulting in nearly 1.5 million deaths annually [1]. These infections encompass a broad spectrum, ranging from superficial mycoses such as tinea versicolor, moniliasis, and dermatophytosis to more severe cutaneous, subcutaneous, and systemic manifestations. Conventional therapies are increasingly hampered by issues such as poor skin permeation, drug resistance, and unwanted side effects. Recent advances in nanotechnology have paved the way for the development of nanogel-based drug delivery systems which promise enhanced targeting, controlled release, and improved bioavailability of antifungal agents [1,2]. Nanogels are hydrogel nanoparticles—typically in the 20–200 nanometer range—comprising crosslinked hydrophilic polymers that swell in aqueous environments, thereby offering unique advantages for topical and systemic drug delivery applications. Their ability to incorporate both hydrophilic and hydrophobic drugs, coupled with their tunable physicochemical properties, marks them as promising candidates for combating the limitations of conventional antifungal therapies [1]. In this review, we provide a comprehensive analysis of nanogel-based antifungal drug delivery systems, delving into their fundamental properties, synthesis and formulation methods, evaluation parameters, clinical applications, and the challenges that remain as well as prospective future directions. Nanogels are submicron-scale, three-dimensional polymeric networks formed by the crosslinking of hydrophilic polymers. Their nanoscale size facilitates enhanced penetration through biological barriers, while their high-water content and soft consistency render them biocompatible and favorable for controlled drug release applications.

Composition and Structure

Nanogels are typically composed of polymers that can be either naturally derived or synthetically produced. These polymers may include poly (ethylene glycol), chitosan, Carbopol, and many others that exhibit hydrophilic characteristics. The crosslinking within the gel network can be achieved through chemical (covalent) or physical (non-covalent) interactions. For instance, covalent crosslinking methods, such as free radical polymerization or the Schiff base reaction, produce stable nanogels ideal for sustained release applications4. In contrast, non-covalent interactions based on hydrogen bonding or hydrophobic contacts offer a dynamic and responsive network that may be sensitive to environmental stimuli like pH or temperature [3].

Key Physicochemical Properties

Nanogels possess several desirable physicochemical properties that underpin their function as drug delivery vehicles:

Swelling Behavior in Aqueous Media: Nanogels swell in water due to solvent penetration into the polymeric network. The swelling can alter the nanogel's dimensions, influencing drug release kinetics via diffusion mechanisms, osmotic pressure, and polymer elasticity [1,3].

Particle Size and Distribution: Typically ranging from 20 nm to 200 nm, the compact size of nanogels allows them to evade rapid clearance by the reticuloendothelial system. Their small dimensions also facilitate the passage through tight intercellular junctions and potentially across challenging barriers such as the blood–brain barrier [4].

High Drug Loading Capacity: The extensive surface area and internal microenvironment of nanogels support high levels of drug encapsulation. This capacity is further enhanced by the possibility to tailor the crosslinking density, thereby controlling the drug release profile [1].

Biocompatibility and Degradability: An essential feature for clinical usage is the minimal toxicity associated with nanogels. Their biodegradability depends on the choice of polymer and crosslinking strategy, ensuring that breakdown products can be safely eliminated from the body [4].

Advantages and Disadvantages:

The benefits of nanogels in antifungal drug delivery are accompanied by certain limitations. The table below summarizes key advantages and disadvantages:

Nanogels have emerged as a highly promising approach in antifungal therapy due to their multifaceted design features and functional properties.

Synthesis and Formulation Strategies

Developing nanogels for antifungal drug delivery involves sophisticated synthesis and formulation methods that warrant precise control over particle size, drug encapsulation, and release characteristics. In this section, we discuss the techniques used for synthesizing these nanocarriers and their formulation strategies. [6]

Physical Methods

Physical synthesis methods are often used due to their simplicity and reproducibility. These include:

Microfluidics: Utilizing capillary channels made from silica or glass, microfluidic systems allow precise control of droplet formation, yielding uniform nanogel particles. This technique is particularly valuable for reproducibly creating droplets with narrow size distributions [7].

Emulsion Technology: Tiny emulsion techniques, including the mini-emulsion method, are employed to create water-in-oil or oil-in-water emulsions. The formation of a stable emulsion is achieved by continuous organic phases and the use of oil-soluble surfactants. Once stabilized, the droplets are crosslinked to form nanogels.

Inverse Nanoprecipitation: This method entails mixing an aqueous polymer solution with a miscible non-solvent, leading to the systematic formation of aqueous nanogels. The rapid mixing under controlled conditions is beneficial for achieving a narrow particle size distribution [6].

Chemical Crosslinking Approaches

Chemical strategies for nanogel synthesis involve forming covalent bonds between polymer chain segments. The following crosslinking methods are commonly employed:

Covalent Crosslinking: This method uses free radical polymerization or the Schiff base reaction to obtain strong and stable nanogels. Covalently crosslinked nanogels exhibit superior structural stability, making them suitable for sustained drug release applications.

Non-Covalent (Physical) Crosslinking: In contrast, physical interactions such as hydrogen bonding or hydrophobic interactions are used to form a looser network. Although these nanogels are less stable, they often provide stimuli-responsive drug release, which is highly desirable for on-demand delivery.

Bioconjugation Techniques: These techniques involve incorporating functional sub- initiators or micro initiators to guide polymerization under milder conditions. Free radical polymerization adapted for bioconjugation can yield core-shell nanogels with targeted biofunctionalities [7.8].

Herbal Extraction and Integration into Nanogels

An emerging trend in nanogel formulation is the incorporation of herbal extracts with intrinsic antifungal properties. Plants like Eugenia uniflora, Psidium guajava, Curcuma longa, and others have been exploited for their bioactive compounds. Extraction techniques for such herbal ingredients include:

Microwave-Assisted Extraction (MAE): This modern method uses microwave energy to accelerate extraction. It has been demonstrated to be effective in preserving thermolabile compounds while reducing extraction time.

Maceration and Infusion: Such traditional methods involve soaking plant material in suitable solvents (e.g., water, ethanol) to release bioactive compounds. Despite being time- consuming, these techniques are gentle and preserve the native structure of herbal molecules [9].

Formulation Strategies and Case Studies:

Recent developments in formulation strategies have led to innovative delivery systems that combine the benefits of nano emulsions with the structural characteristics of nanogels. A notable example is the Vitamin E TPGS (D-α-tocopheryl polyethylene glycol succinate) based nanogel developed for the delivery of high molecular weight antifungal drugs such as amphotericin B2. In this formulation, the nanoemulsion is first optimized for surfactant/co-surfactant ratios, globule size, percent transmittance, viscosity, and rheology. The optimized nanoemulsion is then incorporated into a gel base to impart improved skin retention and permeation properties. This system demonstrated a 3.9-fold increase in skin deposition compared to the marketed formulation and exhibited enhanced antifungal activity, with a 2.0-fold higher effect against pathogens such as Aspergillus niger and Candida albican

Figure 1: Synthesis Process Flow for Nanogel Fabrication and Formulation Strategies

 The diagram above summarizes the sequential steps in the development of a nanogel-based antifungal delivery system, highlighting the key decision points including the choice between physical and chemical synthesis routes, incorporation of active therapeutic and herbal ingredients, and the final assessment of particle size and stability.

Characterization and Evaluation Of Nanogel Systems

The successful translation of nanogel formulations into clinical applications relies on comprehensive characterization and evaluation protocols. Evaluating the physicochemical, mechanical, and biological properties of nanogel systems ensures that the formulation meets the intended therapeutic goals while maintaining safety and efficacy. [10]

Physicochemical Characterization

A detailed analysis of the physicochemical properties is crucial for understanding the performance of nanogel formulations:

Particle Size and Polydispersity Index (PDI): Instruments such as the Malvern Mastersizer or Zeta sizer are used to determine the mean particle size and distribution. A narrow PDI indicates uniform particle size, which is critical for predictable drug release and bioavailability.

pH Measurement: The pH of the nanogel formulation is measured using digital pH meters to ensure compatibility with the skin’s natural pH (approximately 5.5–6.0). Deviations in pH can lead to irritation or reduced efficacy.

Drug Loading and Encapsulation Efficiency: Determination of drug content is performed using analytical techniques such as UV–Vis spectrophotometry and high- performance liquid chromatography (HPLC). Accurate quantification guarantees that the therapeutic dose is delivered effectively [7].

Viscosity and Spreadability: Viscosity measurements using rheometers (e.g., Brookfield rheometers) are essential to evaluate the ease of application, while spreadability tests assess the formulation’s suitability for topical delivery. These parameters directly influence patient compliance and the uniformity of drug distribution on the skin [11].

Morphological Analysis

Microscopic techniques are employed to observe the surface morphology and structural integrity of the nanogels:

• Scanning Electron Microscopy (SEM): SEM imaging provides high-resolution details of the nanogel surface, revealing the degree of aggregation, pore structure, and overall homogeneity of the formulation. This analysis is critical for correlating the physical characteristics with drug release profiles.
• Fourier Transform Infrared Spectroscopy (FTIR): FTIR is used to confirm the chemical interactions between the nanogel matrix and encapsulated drugs. Specific absorption peaks indicate successful crosslinking and can be used to detect any residual reactive groups. [12]

In Vitro and Ex Vivo Evaluations:

Evaluating the performance of nanogel formulations under laboratory conditions serves as a precursor to clinical testing:

• In Vitro Drug Release Studies: Utilizing devices such as the Franz Diffusion Cell, researchers quantify the release profile of antifungal agents from nanogels. The controlled release characteristics, as evidenced by gradual drug liberation, are indicative of the successful formation of the nanogel structure.
• Skin Permeation and Deposition Studies: Ex vivo studies using porcine or human skin models, combined with confocal laser scanning microscopy (CLSM), reveal the depth of skin penetration and distribution of the nanogel. For instance, Vitamin E TPGS nanogel formulations have demonstrated up to 3.9-fold higher skin deposition compared to conventional products, with clear permeation into deeper skin layers [10].
• Antifungal Efficacy Testing: The antifungal activity of the nanogel is assessed using microdilution methods, wherein the minimal inhibitory concentration (MIC) is determined for pathogens like Aspergillus niger and Candida albicans. Enhanced antifungal effects, sometimes up to 2.0-fold compared to marketed formulations, validate the therapeutic potential of the nanogel [13].

Evaluation Summary Table:

The table below outlines the key evaluation parameters for nanogel-based antifungal formulations:

Table 1: Comprehensive Evaluation Parameters for Nanogel-Based Antifungal Formulations

Applications In Antifungal Therapy:

Nanogel-based drug delivery systems have been extensively investigated for their potential to revolutionize antifungal therapy. Their inherent properties allow for precision targeting and controlled release, which are critical for addressing localized and systemic fungal infections.

Topical Delivery for Skin Infections

One of the primary applications of nanogel formulations is the treatment of a range of skin infections. Topical antifungal agents, when delivered via nanogels, benefit from enhanced permeation, prolonged retention in the skin layers, and reduced systemic side effects. For instance, the incorporation of high molecular weight drugs such as amphotericin B into a Vitamin E TPGS nanogel has demonstrated remarkable improvements. In a study conducted by Kaur, Jain, and Singh, the optimized nanogel formulation showed a 3.9-fold increase in skin deposition when applied to porcine ear skin compared to conventional topical formulations [14]. Furthermore, the controlled release profile ensured a steady therapeutic concentration at the target site, reducing the frequency of application and minimizing the risk of toxicity.

Nanoemulsion-Based Nanogels

Nanoemulsions, characterized by their ultrafine droplet size and high surface area, have been integrated into nanogel matrices to further enhance drug delivery. Nanoemulsion-based nanogels provide additional benefits such as improved solubilization of hydrophobic antifungal drugs, increased colloidal stability, and superior mucoadhesive properties that are particularly useful for mucosal infections. A recent review highlighted that nanoemulsion-based nanogels are significantly more effective in delivering antifungal agents such as fluconazole, amphotericin B, and clotrimazole. These formulations not only enhance the antifungal efficacy but also reduce adverse effects, making them viable alternatives for managing refractory fungal infections [15].

Integration of Herbal Extracts

Herbal extracts with known antifungal properties have also found their place in nanogel therapeutics. The utilization of bioactive compounds from natural sources—such as Curcuma longa (turmeric), Eugenia uniflora, and Psidium guajava—provides added therapeutic benefits due to their anti-inflammatory, antioxidant, and antimicrobial activities. Incorporating these extracts into nanogel formulations leverages the dual benefits of direct antifungal activity and enhanced drug permeation. The integration process involves careful optimization of herbal extract concentration, solvent selection (e.g., water, ethanol), and extraction techniques such as maceration and microwave-assisted extraction4. By combining herbal actives with conventional antifungal drugs, nanogels offer synergistic effects that may overcome drug resistance and improve patient outcomes. [16]

Additional Therapeutic Applications

Beyond topical antifungal therapy, nanogel systems have been explored for other medical applications including:

Vaccine Delivery: Nanogels can serve as carriers for antigens and nucleic acid–based vaccines, potentially enhancing immune responses by facilitating targeted delivery [17].

Anti-Inflammatory Applications: Nanogels loaded with non-steroidal anti-inflammatory drugs (NSAIDs) offer controlled release profiles that reduce systemic side effects and improve local efficacy in inflammatory conditions such as psoriatic plaques and allergic contact dermatitis.

Central Nervous System (CNS) Delivery: Certain nanogel formulations have been optimized for the delivery of hydrophilic drugs across the blood–brain barrier, thus providing potential therapeutic strategies for neurological disorders.

Local Anesthetics and Anticancer Therapy: The precise delivery capabilities of nanogels have been utilized in the formulation of local anesthetic agents and chemotherapeutics, thereby improving drug distribution and reducing adverse effects in localized applications [18]. In summary, the versatility and adaptability of nanogel-based drug delivery systems have positioned them as a frontier technology in antifungal therapy and several other domains of medicine.

CHALLENGES AND FUTURE PERSPECTIVES

Despite significant advancements, several challenges remain in the development and clinical translation of nanogel-based antifungal drug delivery systems. Addressing these issues is critical for the future success of nanogel therapeutics.

Safety and Toxicity Concerns

One of the principal challenges associated with nanogel formulation is ensuring that the final product is both safe and non-toxic. Residual monomers or surfactants, if not completely removed during the synthesis process, can lead to cytotoxicity. Furthermore, biodegradability and the nature of the breakdown products must be carefully assessed. Long-term in vivo studies are necessary to fully understand the potential immunogenic and toxicological profiles of these materials [19,20].

Stability and Scalability

Ensuring the physical and chemical stability of nanogel formulations during storage and transportation is paramount. Many nanogel systems may exhibit aggregation or changes in particle size distribution over time, which can compromise therapeutic efficacy. Moreover, the batch-to- batch reproducibility and large-scale manufacturing of nanogels remain challenging. Advancements in synthesis techniques that allow for precise control over formulation parameters are needed to overcome these issues [21,22].

Regulatory and Clinical Translation

Despite encouraging preclinical results, regulatory hurdles and the complexity of clinical translation remain significant barriers. Nanomedicine falls into a regulatory gray area where established guidelines may not fully address the nuances of nanoparticulate formulations. Collaborative efforts between academic researchers, industry partners, and regulatory bodies are essential to develop standardized protocols and safety benchmarks that will facilitate clinical acceptance [23].

 FUTURE RESEARCH DIRECTIONS

Looking ahead, several promising avenues warrant further exploration:

Targeted Delivery: Advances in surface functionalization of nanogels could enable the specific targeting of fungal cells or infection sites. Conjugation of targeting ligands may ensure that the therapeutic agents are delivered precisely, reducing off-target effects and improving efficacy [24].

Stimuli-Responsive Nanogels: Future formulations may incorporate stimuli-responsive elements that trigger drug release in response to specific environmental cues such as pH, temperature, or enzymatic activity, further personalizing treatment outcomes.

Combination Therapies: Integrated nanogel platforms that co-deliver antifungal agents alongside anti-inflammatory or immunomodulatory compounds could offer synergistic therapeutic benefits and address multifactorial pathologies. [25]

Enhanced Imaging and Monitoring: Incorporating imaging agents within the nanogels may allow real-time monitoring of drug distribution and metabolism, enabling feedback- controlled release systems for precision medicine. [26]

Future Perspectives Visualization

The following table provides an overview of the current challenges and potential future strategies in nanogel development for antifungal therapy:

Table 2: Challenges and Future Strategies in Nanogel-Based Antifungal Therapy